Skip to main content
. Author manuscript; available in PMC: 2021 Jul 8.
Published in final edited form as: Neuropharmacology. 2020 Sep 22;181:108333. doi: 10.1016/j.neuropharm.2020.108333

Table 1.

Zuranolone exhibited PAM activity at all GABAA receptors tested.

Receptor Type EC50 (nM) Emax (%) Cell type
α4β3δ 118 556 CHO
α1β2γ2 430 1037 Ltk
α2β2γ2 184 1343 Ltk
α1β3γ2 390 684 HEK293
α2β3γ2 516 1045 HEK293
α3β3γ2 293 291 HEK293
α5β3γ2 298 534 HEK293
α1β1γ2 1260 1435 Xenopus oocytes
α6β3δ 780 1590 Xenopus oocytes